Seattle, WA, United States of America

Ronald James Hause, Jr

This inventor holds 2 USPTO granted patents and 14 published patent applications and 1 EPO patent. Top assignee: Juno Therapeutics Gmbh. Active years: 2023-2024.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Ronald James Hause, Jr. Retrieved from https://idiyas.com/inventor/ronald-james-hause-jr

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 2 

% Patents Active = 100.0

 

Average Co-Inventor Count = 6.9

ph-index = 1


Company Filing History:


Years Active: 2023-2024

Loading Chart...
Loading Chart...
2 patents (USPTO):Explore Patents

Title: Innovations of Ronald James Hause, Jr.

Introduction

Ronald James Hause, Jr. is a notable inventor based in Seattle, WA (US). He has made significant contributions to the field of cell therapy, holding two patents that focus on innovative methods and compositions for therapeutic applications. His work is pivotal in advancing the understanding and effectiveness of cell-based treatments.

Latest Patents

Hause's latest patents include "Phenotypic markers for cell therapy and related methods." This patent provides methods, compositions, and articles of manufacture for use in cell therapy involving the administration of therapeutic T cell compositions. The T cell compositions express recombinant receptors, such as chimeric antigen receptors (CARs) or other transgenic receptors. The features of this patent offer advantages like consistent dosing, reduced risk of toxicity, and enhanced response in subjects receiving the T cell compositions.

Another significant patent is "Epigenetic analysis of cell therapy and related methods." This patent outlines methods for identifying genomic regions predictive of treatment outcomes with cell therapy. It includes epigenetic and epigenomic analyses of cells, which are crucial for preparing engineered cells for therapy and predicting responses. The methods assess changes in epigenetic properties, such as chromatin accessibility and DNA methylation, which are essential for understanding cell behavior in therapeutic contexts.

Career Highlights

Hause is currently associated with Juno Therapeutics GmbH, where he applies his expertise in cell therapy. His work at Juno Therapeutics is instrumental in developing innovative treatments that leverage the power of engineered cells. His contributions have the potential to transform patient care in various medical fields.

Collaborations

Some of his notable coworkers include Ryan P Larson and Kedar Himanshu Dave. Their collaborative efforts contribute to the advancement of research and development in cell therapy, enhancing the potential for successful therapeutic outcomes.

Conclusion

Ronald James Hause, Jr. is a distinguished inventor whose work in cell therapy is shaping the future of medical treatments. His patents reflect a commitment to innovation and excellence in the field, making significant strides toward improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…